Core Viewpoint - The U.S. Food and Drug Administration (FDA) has declined to approve Outlook Therapeutics' drug for a specific type of eye disease, representing a significant setback in the company's ongoing efforts [1] Company Summary - Outlook Therapeutics has faced a prolonged effort to gain approval for its drug, which has now been rejected by the FDA [1]